Brief: Qsam Biosciences Provides Update To Shareholders On Phase 1 Progress And Preliminary Clinical Data
16/08/2023 13:13
Qsam Biosciences Inc QSAM.PK :
* QSAM BIOSCIENCES PROVIDES UPDATE TO SHAREHOLDERS ON PHASE
1
PROGRESS AND PRELIMINARY CLINICAL DATA
Source text for Eikon: ID:nGNX7ztZNM
Further company coverage: QSAM.PK
Recent news on Qsam Biosciences
See all newsBrief: QSAM Biosciences Signs Definitive Agreement To Be Acquired By Telix Pharmaceuticals
Brief: Qsam Biosciences Says Co Granted Telix An Additional 30 Days Under Exclusivity Period To Complete Its Due Diligence
Brief: Qsam Biosciences Signs Term Sheet To Be Acquired By Telix Pharmaceuticals Receives $2 Million Pre-Closing Collaboration And Option Fee
Brief: Telix Pharmaceuticals Announces Proposed Acquisition Of QSAM Biosciences
Brief: Qsam Biosciences Provides Update To Shareholders On Phase 1 Progress And Preliminary Clinical Data